Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance

Chen Guangli , Liu Yingpeng , Wang Jianting , Luo Linghui , Chen Pei , Ding Juan , Gong Shusheng

Current Medical Science ›› 2006, Vol. 26 ›› Issue (30) : 105 -107.

PDF
Current Medical Science ›› 2006, Vol. 26 ›› Issue (30) : 105 -107. DOI: 10.1007/BF02828052
Article

Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance

Author information +
History +
PDF

Abstract

In order to study the expressions of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in human laryngeal squamous cell carcinoma (LSCC) and its significance, the expression of VEGF mRNA and COX-2 mRNA in 62 cases of LSCC and 54 adjacent noncancerous laryngeal tissues and 9 normal human laryngeal mucous tissues was detected by using techniques of semi-quantitative RT-PCR. It was found that the expression level of VEGF and COX-2 mRNA was significantly increased in LSCC as compared with that in the normal human laryngeal mucous tissues (bothP<0.01), and the expression level of VEGF and COX-2 mRNA were significantly increased in stage III+IV tissues of LSCC as compared with the stage I+II tissues of LSCC (P<0.01). There was a high positive correlation between VEGF and COX-2 expression in LSCC (r=0.756,P<0.01). These data raise the possibility that VEGF and COX-2 may play key roles in the growth, invasion and metastasis of LSCC.

Keywords

laryngcal squamous cell carcinoma / VEGF / COX-2 / RT-PCR

Cite this article

Download citation ▾
Chen Guangli, Liu Yingpeng, Wang Jianting, Luo Linghui, Chen Pei, Ding Juan, Gong Shusheng. Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance. Current Medical Science, 2006, 26(30): 105-107 DOI:10.1007/BF02828052

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

HolashJ, WiegandS J, YancopoulosG D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene, 1999, 18(38): 5356-5362

[2]

ColoradoP C, TorreA, KamphausG, et al.. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res, 2000, 60(9): 2520-2526

[3]

BrownL F, BerseB, JackmanR W, et al.. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 1993, 53(19): 4727-4735

[4]

BoxerG M, TsiompanouE, LevineT, et al.. Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. Tumour Biol, 2005, 26(1): 1-8

[5]

YamauchiT, WatanabeM, KubotaT, et al.. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum, 2002, 45(1): 98-103

[6]

EliY, PrzedeckiF, LevinG, et al.. Comparative effects of indomethacin on cell proliferation and cell cycle, progression in tumor cells grownin vitro andin vivo. Biochem Pharmacol, 2001, 61(5): 565-571

[7]

TangT C, RonnieT. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol, 2005, 11(13): 1896-1902

[8]

YuanA, YuC J, ShunC T, et al.. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer, 2005, 115(4): 545-555

AI Summary AI Mindmap
PDF

73

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/